1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6AF094D6292BDB19285257A0F0057B871
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/implementing-early-warning-systems-effectiveness-contingency-plans?opendocument
18
19opendocument
2044.192.49.72
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Business Operations » Strategic Planning and Management

Crisis Management & Business Continuity Excellence: Planning, Communication, and Risk Mitigation for BioPharma Manufacturing

ID: 5205


Features:

12 Info Graphics

18 Data Graphics

150+ Metrics

7 Narratives

2 Best Practices


Pages/Slides: 37


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Crisis Management & Business Continuity Excellence: Planning, Communication, and Risk Mitigation for BioPharma Manufacturing"


STUDY OVERVIEW

Rising concerns about the quality of systems and the management of resources surrounding Crisis Management are forcing companies to evaluate their processes and revisit planning for such events. As a result, the tools and techniques around developing a Business Continuity Plan are becoming more valuable to evaluate a company's response time to a crisis. Ultimately, executives must cultivate a preventative mind-set and corresponding capabilities in order to be prepared for major disasters or operating disruptions.

Best Practices, LLC conducted this study to investigate approaches to planning, communication and managing risk that national and global health care organizations use as part of an Integrated Business Continuity Plan. The study includes benchmarks around designing and implementing early warning systems as well as methods used to test the effectiveness of current contingency plans. Executives can use this study to evaluate the comprehensiveness of their systems and the effectiveness of their communication strategy in response to events such as disruption of a major operations asset.

The study includes two segments: a large health care segment and a small/emerging health care and clinic segment.

KEY TOPICS

  • Assembling the Tools and Techniques to Build an Integrated Business Continuity Plan
  • Developing a Prevention Mind-set and Fast Response
  • Using Backups & Redundancy Management
  • Importance of Communication During Crisis

SAMPLE KEY METRICS
  • IT group involvement in Business Continuity Planning
  • Elements included in Crisis Management Plan/ Procedure
  • Escalation Process in place to resolve a Crisis
  • Approaches employed to plan and prepare for risks that may happen very infrequently
  • Methods used to test comprehensiveness and effectiveness of contingency plans
  • Key learnings based upon responses to real events
  • Most effective approaches to designing and implementing early warning systems
  • Technologies employed in proactive response systems and programs
  • Current or predicted level of impact new technologies will have in helping to improve reliability
  • Systems installed to facilitate recovery from the loss of a major operations asset
  • Level of concern for different factors in terms of potential business disruption risk
  • Rating of most important capabilities to manufacturing operations
  • Internal Communications employed to keep employees and other key stakeholders informed during low-frequency, high-impact events
  • Approaches employed to keep regulatory bodies and other local and community authorities informed during low-frequency, high-impact events
  • Anticipated changes in contingency activities over the next three years

SAMPLE KEY FINDING
  • Most Companies Employ Some Redundancy Management To Prevent Disruptions: A majority of companies have use in-service spares, duplicate production or fully redundant systems to ensure reliability during operational disruptions.
  • During Major Events: Communicate Early & Often: Active communication is a critical tool for managing through crisis. Daily briefings are advocated by 86% of the benchmark class and sharing of lessons learned is used by 71% of companies.
METHODOLOGY

The research is based on the insights of 33 Business Continuity (BC) leaders from 29 national and global health care organizations. In addition, selected executives provided qualitative insights through deep-dive interviews and “lessons learned” observations.

Industries Profiled:
Biotech; Pharmaceutical; Medical; Manufacturing; Medical Device; Health Care; Diagnostic; Biopharmaceutical; Clinical Research; Laboratories; Consumer Products; Chemical


Companies Profiled:
Amgen; Alameda County Medical Center; Insight Adhesives Research; Siemens Medical; Nypro; GlaxoSmithKline; Abbott; UCB Pharma; Genzyme; Shire; Fibrogen; Terumo Corporation; Sanofi; Merck; Ipsen; Amylin; Lilly; Boehringer Ingelheim; Boston Scientific; Bayer Healthcare; Johnson & Johnson; Genentech; EMD Serono; Ben Venue Laboratories; Janssen; Smith & Nephew; Grifols; MedImmune

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.